U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Sold by Azzad Asset Management Inc. ADV

Azzad Asset Management Inc. ADV reduced its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 4.0% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 16,188 shares of the company’s stock after selling 668 shares during the quarter. Azzad Asset Management Inc. ADV owned approximately 0.11% of U.S. Physical Therapy worth $1,827,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Benjamin Edwards Inc. boosted its position in shares of U.S. Physical Therapy by 17.4% during the 4th quarter. Benjamin Edwards Inc. now owns 1,692 shares of the company’s stock worth $158,000 after acquiring an additional 251 shares in the last quarter. True North Advisors LLC boosted its position in shares of U.S. Physical Therapy by 4.6% during the 4th quarter. True North Advisors LLC now owns 6,019 shares of the company’s stock worth $561,000 after acquiring an additional 265 shares in the last quarter. SRS Capital Advisors Inc. boosted its position in shares of U.S. Physical Therapy by 308.0% during the 4th quarter. SRS Capital Advisors Inc. now owns 408 shares of the company’s stock worth $38,000 after acquiring an additional 308 shares in the last quarter. Bridge City Capital LLC boosted its position in shares of U.S. Physical Therapy by 1.1% during the 3rd quarter. Bridge City Capital LLC now owns 31,372 shares of the company’s stock worth $2,878,000 after acquiring an additional 336 shares in the last quarter. Finally, Personal CFO Solutions LLC boosted its position in shares of U.S. Physical Therapy by 8.5% during the 4th quarter. Personal CFO Solutions LLC now owns 4,849 shares of the company’s stock worth $452,000 after acquiring an additional 379 shares in the last quarter.

U.S. Physical Therapy Stock Up 1.5 %

Shares of NYSE USPH opened at $92.95 on Thursday. The stock has a market cap of $1.40 billion, a PE ratio of 75.57, a price-to-earnings-growth ratio of 3.56 and a beta of 1.38. The company has a quick ratio of 2.16, a current ratio of 2.16 and a debt-to-equity ratio of 0.28. U.S. Physical Therapy, Inc. has a 52-week low of $78.08 and a 52-week high of $124.11. The business has a 50-day moving average price of $99.66 and a 200 day moving average price of $99.85.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Tuesday, May 7th. The company reported $0.51 EPS for the quarter, missing the consensus estimate of $0.58 by ($0.07). The company had revenue of $155.70 million for the quarter, compared to analysts’ expectations of $153.30 million. U.S. Physical Therapy had a net margin of 4.72% and a return on equity of 8.03%. The firm’s revenue was up 4.8% on a year-over-year basis. During the same period in the prior year, the company earned $0.59 earnings per share. Equities research analysts forecast that U.S. Physical Therapy, Inc. will post 2.84 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 14th. Shareholders of record on Thursday, May 23rd were paid a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a yield of 1.89%. The ex-dividend date was Wednesday, May 22nd. U.S. Physical Therapy’s dividend payout ratio is presently 143.09%.

Wall Street Analyst Weigh In

USPH has been the subject of several analyst reports. Barrington Research reaffirmed an “outperform” rating and set a $122.00 price objective on shares of U.S. Physical Therapy in a research report on Thursday, May 9th. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Monday, March 18th. Finally, JPMorgan Chase & Co. upped their target price on U.S. Physical Therapy from $99.00 to $117.00 and gave the company an “overweight” rating in a research report on Wednesday, March 13th. One investment analyst has rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $119.50.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, CEO Christopher J. Reading sold 2,900 shares of the company’s stock in a transaction that occurred on Thursday, May 30th. The stock was sold at an average price of $100.26, for a total transaction of $290,754.00. Following the completion of the sale, the chief executive officer now directly owns 95,838 shares of the company’s stock, valued at approximately $9,608,717.88. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, CEO Christopher J. Reading sold 1,100 shares of the firm’s stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $102.13, for a total value of $112,343.00. Following the completion of the sale, the chief executive officer now directly owns 99,738 shares of the company’s stock, valued at approximately $10,186,241.94. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Christopher J. Reading sold 2,900 shares of the firm’s stock in a transaction that occurred on Thursday, May 30th. The shares were sold at an average price of $100.26, for a total value of $290,754.00. Following the completion of the sale, the chief executive officer now directly owns 95,838 shares of the company’s stock, valued at $9,608,717.88. The disclosure for this sale can be found here. Insiders sold a total of 10,724 shares of company stock valued at $1,114,385 in the last ninety days. Insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.